FDA.reportPublic FDA data

Application 209296

Type
NDA
Sponsor
HERON THERAPS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CINVANTIAPREPITANTEMULSION;INTRAVENOUS130MG/18ML (7.2MG/ML)YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
47426-201CINVANTIaprepitantHeron Therapeutics, Inc.NDACurrent
47426-201CINVANTIaprepitantHeron Therapeutics, Inc.NDACurrent
47426-201CINVANTIaprepitantHeron Therapeutics, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77721SUPPL 2024-03-05
77716SUPPL 2024-03-05
70796SUPPL2022-04-20
70522SUPPL2022-03-15
60632SUPPL2019-10-22
60630SUPPL2019-10-22
57833SUPPL2019-02-28
57823SUPPL2019-02-27
52881ORIG2018-03-09
50385ORIG2017-11-13
50368ORIG2017-11-13